Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aebi, H. 1984. Catalase in vitro. Methods Enzymol. 105:121–126
Baysal, B.E., Ferrell, R.E., Willett-Brozick, J.E., Lawrence, E.C., Myssiorek, D., Bosch, A., van der Mey, A., Taschner, P.E., Rubinstein, W.S., Myers, E.N., Richard, C.W. III, Cornelisse, C.J., Devilee, P., Devlin, B. 2000. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287:848–851
Beurdeley-Thomas, A., Miccoli, L., Oudard, S., Dutrillaux, B., and Poupon, M.F. 2000. The peripheral benzodiazepine receptors: A review. J. Neurooncol. 46:45–56
Bianchi, N.O., Bianchi, M.S., Richard, S.M. 2001. Mitochondrial genome instability in human cancers. Mutat. Res. 488:9–23
Boddapati, S.V., Tongcharoensirikul, P., Hanson, R.N., D’Souza, G.G., Torchilin, V.P., Weissig, V. 2005. Mitochondriotropic liposomes. J. Liposome Res. 15:49–58
Bonnet, S., Archer, S.L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C.T., Lopaschuk, G.D., Puttagunta, L., Bonnet, S., Harry, G., Hashimoto, K., Porter, C.J., Andrade, M.A., Thebaud, B., Michelakis, E.D. 2007. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell. 11:37–51.
Borutaite, V., Budriunaite, A., and Brown, G.C. 2000. Reversal of nitric oxide-, peroxynitrite- andS-nitrosothiol-induced inhibition of mitochondrial respiration or complex I activity by light and thiols. Biochim. Biophys. Acta 1459:405–412
Boveris, A., and Chance, B. 1973. The mitochondrial generation of hydrogen peroxide. Biochem. J. 134:707–716
Brand, M.D., Affouritt, C., Esteves, T.C., Green, K., Lambert, A.J., Miwa, S., Pakay, J.L., and Parker, N. 2004. Free Radic. Biol. Med. 37:755–767
Brimmell, M., Mendiola, R., Mangion, J., and Packham, G. 1998. BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability. Oncogene 16:1803–1812
Brookes, P.S., and Darley-Usmar, V.M. 2002. Hypothesis: The mitochondrial NO signalling pathway, and the transduction from nitrosative to oxidative cell signals: An alternative function for cytochromec oxidase. Free Radic. Biol. Med. 32:370–374
Burwell, L.S., Nadtochiy, S.M., Tompkins, A.J., Young, S., and Brookes, P.S. 2006. Direct evidence for S-nitrosation of mitochondrial complex I. Biochem. J. 394:627–634
Campbell, A.M., and Chan, S.H.P. 2007. The voltage dependent anion channel affects mitochondrial cholesterol distribution and function. Arch. Biochem. Biophys. 466:203–210.
Canter, J.A., Kallianpur, A.R., Parl, F.F., Millikan, R.C. 2005. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res. 65:8028–8033
Capuano, F., Guerrieri, F., and Papa, S. 1997. Oxidative phosphorylation enzymes in normal and neoplastic cell growth. J. Bioenerg. Biomembr. 29:379–384
Carafoli, E. 1980. Mitochondria and disease. Molec. Aspects Med. 3:295–429
Cejas, P., Casado, E., Belda-Iniesta, C., De Castro, J., Espinosa, E., Redondo, A., Sereno, M., Garcia-Cabezas, M.A., Vara, J.A.F., Domingues-Caceres, A., Rosario, P., and Gonzalez-Baron, M. 2004. Implications of oxidative stress and cell membrane lipid peroxidation in human cancer. Cancer Causes Control 15:707–719
Chan, S.H., and Barbour, R.L. 1983. Adenine nucleotide transport in hepatoma mitochondria. Characterization of factors influencing the kinetics of ADP and ATP uptake. Biochim. Biophys. Acta 723:104–113
Chatterjee, A., Mambo, E., Sidransky, D. 2006. Mitochondrial DNA mutations in human cancer. Oncogene 25:4663–4674.
Chen, Y.R., Chen, C.L., Pfeiffer, D.R., and Zweier, J.L. 2007a. Mitochondrial complex II in the post-ischemic heart: Oxidative injury and the role of protein S-glutathionylation. J. Biol.Chem. 282:32640–32654
Chen, C.L., Zhang, L., Yeh, A., Chen, C.A., Green-Church, K.B., Zweier, J.L., and Chen, Y.R. 2007b. Site-specific S-glutathiolation of mitochondrial NADH ubiquinone reductase. Biochemistry 46:5754–5765
Christians, F.C., Newcomb, T.G., and Loeb, L.A. 1995. Potential sources of multiple mutations in human cancers. Prev. Med. 24:329–332
Chu, F.F., Doroshow, J.H., and Esworthy, R.S. 1993. J. Biol. Chem. 4:2571–2576
Chu, F.F., Esworthy, R.S., and Doroshow, J.H. 2004. Free Radic. Biol. Med. 36:1481–1495
Cleeter, M.W.J., Cooper, J.M., Darley-Usmar, V.M., Moncada, S., and Schapira, A.H.V. 1994. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. FEBS Lett. 345:50–54
Clementi, E., Brown, G.C., Feelish, M., and Moncada, S. 1998. Persistent inhibition of cell respiration by nitric oxide: Crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc. Nat. Acad. Sci. USA 95:7631–7636
Covello, K.L., and Simon, M.C. 2004. HIFs, hypoxia, and vascular development. Curr. Topics Dev. Biol. 62:37–54
Coleman, M.C., Asbury, C.R., Daniels, D., Du, J., Aykin-Burns, N., Smith, B.J., Li, L., Spitz, D.R., Cullen, J.J. 2008. 2-Deoxy-d-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer. Free Radic. Biol. Med. 44:322–331
Costantini, P., Jacotot, E., Decaudin, D., Kroemer, G. 2000. Mitochondrion as a novel target of anticancer chemotherapy. J. Natl. Cancer Inst. 92:1042–1053
Dakubo, G.D., Parr, R.L., Costello, L.C., Franklin, R.B., Thayer, R.E. 2006. Altered metabolism and mitochondrial genome in prostate cancer. J. Clin. Pathol. 59:10–16
De Marzo, A.M., Marchi, V.L., Epstein, J.I., Nelson, W.G. 1999. Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis. Am. J. Pathol. 155:1985–1992
Desouki, M.M., Kulawiec, M., Bansal, S., Das, G.M., Singh, K.K. 2005. Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors. Cancer Biol. Ther. 4:1367–1373
Dougherty, T.J., Weishaupt, K.R., and Boyle, D.G. 1985. Photodynamic Sensitizers. J.B. Lipincott, Philadelphia, PA, USA
Douwes Dekker, P.B., Hogendoorn, P.C.W., Kuipers-Dijkshoorn, N., Prins, F.A., van Duinen, S.G., Taschner, P.E.M., van der Mey, A.G.L., and Cornelisse, C.J. 2003. SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology. J. Path. 201:480–486
D’Souza, G.G., Boddapati, S.V., Weissig, V. 2005. Mitochondrial leader sequence—Plasmid DNA conjugates delivered into mammalian cells by DQAsomes co-localize with mitochondria. Mitochondrion 5:352–358
Emerit, I. 1994. Reactive oxygen species, chromosome mutation, and cancer: Possible role of clastogensic factors in carcinogenesis. Free Radic. Biol. Med. 16:99–109
Faure Vigny, H., Heddi, A., Giraud, S., Chautard, D., and Stepien, G. 1996. Expression of oxidative phosphorylation genes in renal tumors and tumoral cell lines. Mol. Carcinog. 16:165–172
Fliss, M.S., Usadel, H., Caballero, O.L., Wu, L., Buta, M.R., Eleff, S.M., Jen, J., Sidransky, D. 2000. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287:2017–2019
Freedland, S.J., Mavropoulos, J., Wang, A., Darshan, M., Demark-Wahnefried, W., Aronson, W.J., Cohen, P., Hwang, D., Peterson, B., Fields, T., Pizzo, S.V., Isaacs, W.B. 2008. Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate 68:11–19
Galiegue, S., Jbilo, O., Combes, T., Bribes, E., Carayon, P., Le Fur, G., and Casellas, P. 1999. Cloning and characterization of PRAX-1. A new protein that specifically interacts with the peripheral benzodiazepine receptor. J. Biol. Chem. 274:2938–2952
Gao, N., Ding, M., Zheng, J.Z., Zhang, Z., Leonard, S.S., Liu, K.J., Shi, X., Jiang, B.H. 2002. Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J. Biol. Chem. 277:31963–31971
Gibson, B.W. 2005. The human mitochondrial proteome: Oxidative stress, protein modifications and oxidative phosphorylation. Int. J. Biochem. Cell Biol. 37:927–934
Gimenez-Roqueplo, A.P., Favier, J., Rustin, P., Mourad, J.J., Plouin, P.F., Corvol, P., Rotig, A., and Jeunemaitre, X. 2001. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activiy of Complex II in the mitochondrial respiratory chain and activities the hypoxia pathway. Am. J. Hum. Genet. 69:1186–1197
Giraud, S., Bonod-Bidaud, C., Wesolowski-Louvel, M., and Stepien, G. 1998. Expression of human ANT2 gene in highly proliferative cells: GRBOX, a new transcriptional element, is involved in the regulation of glycolytic ATP import into mitochondria. J. Mol. Biol. 281:409–418
Gottlieb, E., and Tomlinson, I.P.M. 2005. Mitochondrial tumour suppressors: A genetic and biochemical update. Nat. Rev. Cancer 5:857–866
Gray, M.W. 1992. The endosymbiont hypothesis revisited. Int. Rev. Cytol. 141:233–357
Green, D.E., Loomis, W.F., and Auerbach, V.H. 1948. Studies on the cyclophorase system. I. The complete oxidation of pyruvic acid to carbon dioxide and water. J. Biol. Chem. 172:389–403
Grossman, L.I., and Shoubridge, E.A. 1996. Mitochondrial genetics and human disease. Bioessays 18:983–991
Heerdt, B.G., Halsey, H.K., Lipkin, M., and Augenlicht, L.H. 1990. Expression of mitochondrial cytochromec oxidase in human colonic cell differentiation, transformation, and risk for colonic cancer. Cancer Res. 50:1596–1600
Herrmann, P.C., Gillespie, J.W., Charboneau, L., Bischel, V.E., Paweletz, C.P., Calvert, V.S., Kohn, E.C., Emmert-Buck, M.R., Liotta, L.A., and Petricoin, E.F. 2003. Mitochondrial proteome: Altered cytochromec oxidase subunit levels in prostate cancer. Proteomics 3:1801–1810
Ishii, T., Yasuda, K., Akatsuka, A., Hino, O., Hartman, P.S., and Ishii, N. 2005. A mutation in the SDHC gene of Complex II increases oxidative stress, resulting in apoptosis and tumorigenesis. Cancer Res. 65:203–209
Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., Nakada, K., Honma, Y., Hayashi, J. 2008. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 320:661–664
Jackson, A.L., and Loeb, L.A. 2001. The contribution of endogenous sources of DNA damage to the mutliple mutations in cancer. Mutat. Res. 477:7–21
Jakupciak, J.P., Wang, W., Markowitz, M.E., Ally, D., Coble, M., Srivastava, S., Maitra, A., Barker, P.E., Sidransky, D., O'Connell, C.D. 2005. Mitochondrial DNA as a cancer biomarker. J Mol. Diagn. 7:258–267
Jazayeri, M., Andreyev, A., Will, Y., Ward, M., Anderson, C.M., Clevenger, W. 2003. Inducible expression of a dominant negative DNA polymerase-gamma depletes mitochondrial DNA and produces a rho0 phenotype. J. Biol. Chem. 278:9823–9830
Jiang, W.W., Masayesva, B., Zahurak, M., Carvalho, A.L., Rosenbaum, E., Mambo, E., Zhou, S., Minhas, K., Benoit, N., Westra, W.H., Alberg, A., Sidransky, D., Koch, W., Califano, J. 2005. Increased mitochondrial DNA content in saliva associated with head and neck cancer. Clin Cancer Res 11:2486–2491
Johns, D.R. 1995. Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease. New Engl. J. Med. 333:638–644
Johnson, L.V., Walsh, M.L., Bockus, B.J., Chen, L.B. 1981. Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy. J. Cell Biol. 88:526–535
Klein, E.A., Lipman, S.M., Thompson, I.M., Goddman, P.J., Albanes, D., Taylor, P.R., and Coltman, C. 2003. World J. Urol. 21:21–27
Kono, Y., and Fridovich, I. 1982. Superoxide radical inhibits catalase. J. Biol. Chem. 257:5751–5754
Kowaltowski, A.L., and Vercesi, A.E. 1998. Mitochondrial damage induced by conditions of oxidative stress. Free Radic. Biol. Med. 26:463–471
Kroemer, G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:614–620
Kroemer, G., Galluzzi, L., and Brenner, C. 2007. Mitochondrial membrane permealization in cell death. Physiol. Rev. 87:99–163
Kulawiec, M., Singh, K.K. 2008. In preparation
Lee, H.C., Yin, P.H., Lin, J.C., Wu, C.C., Chen, C.Y., Wu, C.W., Chi, C.W., Tam, T.N., Wei, Y.H. 2005. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann. NY Acad. Sci. 1042:109–122In preparation
Lewis, W., Day, B.J., Kohler, J.J., Hosseini, S.H., Chan, S.S., Green, E.C., Haase, C.P., Keebaugh, E.S., Long, R., Ludaway, T., Russ, R., Steltzer, J., Tioleco, N., Santoianni, R., Copeland, W.C. 2007. Decreased mtDNA, oxidative stress, cardiomyopathy, and death from transgenic cardiac targeted human mutant polymerase gamma. Lab Invest. 87:326–335
Lin, X., Zhang, F., Bradbury, C.M., Kaushal, A., Li, L., Spitz, D.R., Aft, R.L., Gius, D. 2003. 2-Deoxy-d-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism. Cancer Res. 63:3413–3417
Lievre, A., Chapusot, C., Bouvier, A.M., Zinzindohoue, F., Piard, F., Roignot, P., Arnould, L., Beaune, P., Faivre, J., Laurent-Puig, P. 2005. Clinical value of mitochondrial mutations in colorectal cancer. J. Clin. Oncol. 23:3517–3525
Liu, C.S., Tsai, C.S., Kuo, C.L., Chen, H.W., Lii, C.K., Ma, Y.S., and Wei, Y.H. 2003. Oxidative stress-related alteration of the copy number of mitochondrial DNA in human leukocytes. Free Radic. Res. 37:307–1317
Luciakova, K., and Kuzela, S. 1992. Increased steady-state levels of several mitochondrial and nuclear gene transcripts in rat hepatoma with a low content of mitochondria. Eur. J. Biochem. 205:1187–1193
Mambo, E., Chatterjee, A., Xing, M., Tallini, G., Haugen, B.R., Yeung, S.C., Sukumar, S., Sidransky, D. 2005. Tumor-specific changes in mtDNA content in human cancer. Int. J. Cancer 116:920–924
Marnett, L.J. 1999. Lipid peroxidation-DNA damage by malondialdehyde. Mutat. Res. 424:83
Martinez-Cayuela, M. 1995. Oxygen free radicals and human disease. Biochimie 77:47–161
Matoba, S., Kang, J.G., Patino, W.D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P.J., Bunz, F., Hwang, P.M. 2006. p53 regulates mitochondrial respiration. Science 312:1650–1653
McCord, J.M., and Fridovich, I. 1969. An enzymtic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:6049–6055
Mitchell, P. 1961. Coupling of phosphorylation to electron and hydrogen transfer by a chemiosmotic type of mechanism. Nature 191:144–148
Modica-Napolitano, J.S., and Aprille, J.R. 1987. Basis for the selective cytotoxicity of rhodamine 123. Cancer Res. 47:4361–4365
Modica-Napolitano, J.S., Joyal, J.L., Ara, G., Oseroff, A.R., Aprille, J.R. 1990. Mitochondrial toxicity of cationic photosensitizers for photochemotherapy. Cancer Res. 50:7876–7881
Modica-Napolitano, J.S., Koya, K., Weisberg, E., Brunelli, B.T., Li, Y., Chen, L.B. 1996. Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077. Cancer Res. 56:544–550
Modica-Napolitano, J.S., Kulawiec, M., and Singh, K.K. 2007. Mitochondria and human cancer. Curr. Molec. Med. 7:1–11
Modica-Napolitano, J.S., and Touma, S.E. 2000. Functional differences in mitochondrial enzymes from normal epithelial and carcinoma cells. In Mitochondrial Dysfunction in Pathogenesis, A Keystone Symposium, 15–20 January, Santa Fe, NM, USA, Keystone Symposia, Silverthorne, CO, USA64.
Modica-Napolitano, J.S., and Singh, K.K. 2002. Mitochondria as targets for detection and treatment of cancer. Exp. Rev. Mol. Med. 11 April,http://www.expertreviews.org/02004453h.htm
Modica-Napolitano, J., and Singh, K.K. 2004. Mitochondrial dysfunction in cancer. Mitochondrion 4:755–762
Nair, J., Barbin, A., Velic, I., and Bartsch, H. 1999. Etheno DNA-base adducts from endogenous reactive species. Mutat. Res. 424:59
Nelson, D.L., and Cox, M.M. 2000. Lehninger Principles of Biochemistry. Worth Publishers
Neumann, H.P., Pawlu, C., Peczkowaska, M., Bausch, B., McWinney, S.R., Muresan, M., Cuchta, M., Franke, G., Klisch, J., Bley, T.A., et al. 2004. Distinct clinical features of paraglioma syndromes associated with SDHB and SDHD gene mutations. J. Am. Med. Assoc. 292:943–951
Nishikawa, M., Oshitani, N., Matsumoto, T., Nishigami, T., Arakawa, T., Inoue, M. 2005. Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis. Br. J. Cancer 93:331–337
Oberley, L.W. 2001. Antioxidant enzyme levels as a function of growth state in cell culture. Antioxidants Redox Signall. 3:461–472
Oberley, L.W., and Buettner, G.R. 1979. Role of superoxide dismutase in cancer: A review. Cancer Res. 39:1141–1149
O’Gorman, E., Beutner, G., Dolder, M., Koretsky, A.P., Brdiczka, D., and Wallimann, T. 1997. The role of creatine kinase in inhibition of mitochondrial permeability transition. FEBS Lett. 414:253–257
Otto, C., Kaemmerer, U., Illert, B., Muehling, B., Pfetzer, N., Wittig, R., Voelker, H.U., Thiede, A., Coy, J.F. 2008. Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. BMC Cancer 8:122
Pedersen, P.L., and Morris, H.P. 1974. Uncoupler-stimulated adenosine triphosphatase activity. Deficiency in intact mitochondria from Morris hepatomas and ascites tumor cells. J. Biol. Chem. 249:3327–3334
Pedersen, P.L. 1978. Tumor mitochondria and the bioenergetics of cancer cells. Prog. Exp. Tumor Res. 22:190–274
Petit, P.X., and Kroemer, G. 1998. Mitochondrial regulation of apoptosis. In Singh, K.K., ed., Mitochondrial DNA Mutations in Aging, Disease and Cancer Springer-Verlag, Berlin, Germany147–165.
Petros, J.A., Baumann, A.K., Ruiz-Pesini, E., Amin, M.B., Sun, C.Q., Hall, J., Lim, S., Issa, M.M., Flanders, W.D., Hosseini, S.H., Marshall, F.F., Wallace, D.C. 2005. mtDNA mutations increase tumorigenicity in prostate cancer. PNAS 102:719–724
Platz, E.A., and De Marzo, A.M. 2004. Epidemiology of inflammation and prostate cancer. J. Urol. 171:S36–40
Poderoso, J.J., Carreras, M.C., Lisdero, C., Riobo, N., Schopfer, F., and Boveris, A. 1996. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch. Biochem. Biophys. 328:85–92
Pollard, P.J., Briere, J.J., Alam, N.A., Barwell, J., Barclay, E., Wortham, N.C., Hunt, T., Mitchell, M., Olpin, S., Moat, S.J., Hargreaves, I.P., Heales, S.J., Chung, Y.L., Griffiths, J.R., Dalgleish, A., McGrath, J.A., Gleeson, M.J., Hodgson, S.V., Poulsom, R., Rustin, P., and Tomlinson, I.P.M. 2005. Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germlineFH andSDH mutations. Hum. Mol. Genet.14:2231–2239
Polyak, K., Li, Y., Zhu, H., Lengauer, C., Willson, J.K., Markowitz, S.D., Trush, M.A., Kinzler, K.W., Vogelstein, B. 1998. Somatic mutations of the mitochondrial genome in human colorectal tumours Nat. Genet. 20:291–293
Powers, S.K. 1988. In Cerullo, L.J. ed., Application of Lasers in Neurosurgery Year Book Medical Publishers, Chicago, IL, USA137–155.
Pugh, C.W., and Ratcliffe, P.J. 2003. Regulation of angiogenesis by hypoxia: Role of the HIF system. Nat. Med. 9:677–684
Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J.C., and Perucho, M. 1997. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275:967–969
Reed, J.C. 1994. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1–6
Reed, J.C. 1997. Double identity for proteins of the Bcl-2 family. Nature 387:773–776
Schatz, G. 1996. The protein import system of mitochondria. J. Biol. Chem. 271:31763–31766
Schiemann, S., Schwirzke, M., Brunner, N., and Weidle, U.H. 1998. Molecular analysis of two mammary carcinoma cell lines at the transcriptional level as a model system for progression of breast cancer. Clin. Exp. Metast. 16:129–139
Selak, M.A., Armour, S.A., MacKenzie, E.D., Boulahbel, H., Watson, D.G., Mansfield, K.D., Pan, Y., Simon, M.C., Thompson, C.B., and Gottieb, E. 2005. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell7:77–85
Sies, H. 1999. Free Radic. Biol. Med. 27:916–921
Simons, A.L., Ahmad, I.M., Mattson, D.M., Dornfeld, K.J., Spitz, D.R. 2007. 2-Deoxy-d-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells. Cancer Res. 67:3364–3370
Singh, K.K. 1998. Mitochondrial DNA Mutations in Aging, Disease, and Cancer. Springer, New York, USA
Singh, K.K. 2004. Mitochondria damage checkpoint in apoptosis and genome stability. FEMS Yeast Res. 5:127–132
Singh, K.K., Ayyasamy, V., Owens, K., Koul, M.S., Vuciji, M. 2008. Mutations in mitochondrial DNA polymerase γ associated with breast cancer. Submitted
Singh, K.K., Kulawiec, M., Still, I., Desouki, M.M., Geradts, J., Matsui, S. 2005. Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. Gene 354:140–146
Singh, K.K., Russell, J., Sigala, B., Zhang, Y., Williams, J., Keshav, K.F. 1999. Mitochondrial DNA determines the cellular response to cancer therapeutic agents. Oncogene 18:6641–6646
Slane, B.G., Aykin-Burns, N., Smith, B., Kalen, A.K., Goswami, P.C., Domann, F.E., and Spitz, D.R. 2006. Mutation of succinate dehydrogenase subunit C results in increased O2. · −, oxidative stress, and genomic instability. Cancer Res. 66:7615–7620
Spelbrink, J.N., Toivonen, J.M., Hakkaart, G.A., Kurkela, J.M., Cooper, H.M., Lehtinen, S.K., Lecrenier, N., Back, J.W., Speijer, D., Foury, F., Jacobs, H.T. 2000. In vivo functional analysis of the human mitochondrial DNA polymerase POLG expressed in cultured human cells. J Biol Chem. 75:24818–24828.
Spitz, D.R., Azzam, E.I., Li, J.J., and Gius, D. 2004. Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: A unifiying concept in stress response biology. Cancer Metast. 23:311–322
Sul, H.S., Shrago, E., Goldfarb, S., and Rose, F. 1979. Comparison of the adenine nucleotide translocase in hepatomas and rat liver mitochondria. Biochim. Biophys. Acta 551:148–155
Summerhayes, I.C., Lampidis, T.J., Bernal, S.D., Nadakavukaren, J.J., Nadakavukaren, K.K., Shepherd, E.L., and Chen, L.B. 1982. Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. Proc. Natl. Acad. Sci. USA 79:5292–5296
Summerhayes, I.C., Wong, D., and Chen, L.B. 1983. Effect of microtubules and intermediate filaments on mitochondrial distribution. J. Cell Sci. 61:87–105
Sun, A.S., and Cederbaum, A.I. 1980. Oxidoreductase activities in normal rat liver, tumor-bearing rat liver, and hepatoma HC-252. Cancer Res. 40:4677–4681
Sun, A.S., Sepkowitz, K., and Geller, S.A. 1981. A study of some mitochondrial and peroxisomal enzymes in human colonic adenocarcinoma. Lab. Invest. 44:13–17
Suzuki, T., Spitz, D.R., Gandhi, P., Lin, H.Y., and Crawford, D.R. 2002. Mammalian resistance to oxidative stress: A comparative analysis. Gene Expression 10:179–191
Taylor, E.R., Hurrell, F., Shannon, R.J., Lin, T.K., Hirst, J., and Murphy, M.P. 2003. Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J. Biol. Chem. 278:19603–19610
Tomlinson, I.P., Alam, N.A., Rowan, A.J., Barclay, E., Jaeger, E.E., Kelsell, D., Leigh, I., Gorman, P., Lamlum, H., Rahman, S., Roylance, R.R., Olpin, S., Bevan, S., Barker, K., Hearle, N., Houlston, R.S., Kiuru, M., Lehtonen, R., Karhu, A., Vilkki, S., Laiho, P., Eklund, C., Vierimaa, O., Aittomaki, K., Hia, M., Sistonen, P., Paetau, A., Salovaara, R., Herva, R., Launonen, V., Aaltonen, L.A.; 2002. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat. Genetics 30:406–410Multiple Leiomyoma Consortium.
Turrens, J.F. 1997. Superoxide production by the mitochondrial respiratory chain. Biosci. Rep. 17:3–8
Turrens, J.F. 2003. Mitochondrial formation of reactive oxygen species. J. Physiol. 522:335–344
Turrens, J.F., and Boveris, A. 1980. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 191:421–424
Tzagoloff, A. 1982. Mitochondria. Plenum Press, New York, NY, USA
Venturini, I., Zeneroli, M.L., Corsi, L., Avallone, R., Farina, F., Alho, H., Baraldi, C., Ferrarese, C., Pecora, N., Frigo, M., Ardizzone, G., Arrigo, A., Pellici, R., and Baraldi, M. 1998. Up-regulation of peripheral benzodiazepine receptor system in hepatocellular carcinoma. Life Sci. 63:1269–1280
Voet, D., Voet, J.G., and Pratt, C.W. 2002. Fundamentals of Biochemistry. John Wiley & Sons, Inc., New York
Wang, Y., Liu, V.W., Xue, W.C., Tsang, P.C., Cheung, A.N., Ngan, H.Y. 2005. The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: A quantitative study using laser-captured microdissected tissues. Gynecol. Oncol. 98:104–110
Warburg, O. 1930. Metabolism of Tumors. Arnold Constable, London, UK
Warburg, O. 1956. On the origin of cancer cells. Science 123:309–314
Weinhouse, S. 1955. Oxidative metabolism of neoplastic tissue. Adv. Cancer Res. 3:269–325
Weisberg, E.L., Koya, K., Modica-Napolitano, J., Li, Y., Chen, L.B. 1996. In vivo administration of MKT-077 causes partial yet reversible impairment of mitochondrial function. Cancer Res. 56:551–555
Weissig, V., and Torchilin, V.P. 2001. Drug and DNA delivery to mitochondria. Adv. Drug Deliv. Rev. 49:1–2
Wilson, B.C., and Jeeves, W.P. 1987. In Ben-Hur, E., and Rosenthal, I. eds.), Photomedicine, Vol. 2 (CRC Press, Boca Raton, FL, USA127–177.
Woldegiorgis, G., and Shrago, E. 1985. Adenine nucleotide translocase activity and sensitivity to inhibitors in hepatomas. Comparison of the ADP/ATP carrier in mitochondria and in a purified reconstituted liposome system. J. Biol. Chem. 260:7585–7590
Yen, T.C., King, K.L., Lee, H.C., Yeh, S.H., and Wei, Y.H. 1994. Age-dependent increase of mitochondrial DNA deletions together with lipid peroxides and superoxide dismutase in human liver mitochondria. Free Radic. Biol. Med. 16:207–214
Yakes, F.M., and Van Houten, B. 1997. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. USA 94:514–519
Zamzami, N. et al. 1996. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183:1533–1544
Zhang, J., Jin, B., Li, L., Block, E.R., and Patel, J.M. 2005. Nitric oxide-induced persistent inhibition and nitrosylation of active site cysteine residues of mitochondrial cytochrome-c oxidase in lung endothelial cells. Am. J. Physiol. Cell. Physiol. 288:C840–C849
Acknowledgments
Studies in our laboratory were supported by NIH grants R01 CA121904, R01 CA13655, and R01 CA116430. We thank Ms. Paula Jones for editing this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2009 Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Owens, K.M., Modica-Napolitano, J.S., Singh, K.K. (2009). Mitochondria and Cancer. In: Mitochondria and Cancer. Springer, New York, NY. https://doi.org/10.1007/978-0-387-84835-8_1
Download citation
DOI: https://doi.org/10.1007/978-0-387-84835-8_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-84834-1
Online ISBN: 978-0-387-84835-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)